EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reduced-Resistances Model for Enhanced Drug Permeation via a Solubilizing Receiver Medium: A Mechanistic Study with Hollow Fiber Membranes

Jack D Murray iD, Roshni P Patel, Harriet Bennett-Lenane, Patrick J O'Dwyer iD, Brendan T Griffin iD, James E Polli iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Jack D Murray und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University College Cork, Cork T12 K8AF, Ireland. Hauptthemen laut MEDLINE: Technology, Pharmaceutical. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fulbright Commission in Ireland, Taighde ?ireann - Research Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A solubilizing receiver medium has been documented to increase drug flux in vitro, but the mechanisms underlying this effect remain poorly understood. This study investigated these mechanisms and established a mathematical model to describe the increase in apparent permeability. Flow rate experiments were performed to quantify the individual boundary layer and membrane resistances associated with diffusion. The impact of nine solubilizing receiver additives, including surfactants, cyclodextrins, and bovine serum albumin, on the flux of griseofulvin was investigated. The increase in apparent permeability followed the rank-order, though not the magnitude, of the solubility enhancement in the receiver (Spearman's ρ = 0.93, p < 0.001, n = 20). The mechanistic model, termed the reduced-resistances model, demonstrates that a solubilizing receiver reduces diffusional resistance in the membrane and in the receiver-side boundary layer. At high ratios of receiver to donor solubility, a hyperbolic relationship was observed where diffusion through the donor-side boundary layer becomes rate-limiting. Additional drug cocktail permeability studies with antipyrine, phenytoin, and meloxicam confirmed the broader applicability of this model. These findings provide a framework for informed receiver selection in permeability assays and underscore the importance of considering the receiver medium when comparing results across experiments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology, PharmaceuticalAnimalsCyclodextrinsDiffusionGriseofulvinMembranes, ArtificialModels, TheoreticalPermeabilitySerum Albumin, BovineSolubilitySurface-Active Agents

Stichwörter der Autor:innen

Absorption; SolubilityHollow Fiber MembraneMechanistic ModelPermeabilityReceiver Media

Substanzen

CyclodextrinsGriseofulvinMembranes, ArtificialSerum Albumin, BovineSurface-Active Agents

Autor:innen und Institutionen

  • School of Pharmacy, University College Cork, Cork T12 K8AF, Ireland.
  • School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States.

ORCID-Profile: Jack D Murray, Patrick J O'Dwyer, Brendan T Griffin, James E Polli

Förderung

  • Fulbright Commission in Ireland
  • Taighde ?ireann - Research Ireland

Zitieren

APA

Murray, J. D., Patel, R. P., Bennett-Lenane, H., O'Dwyer, P. J., Griffin, B. T., & Polli, J. E. (2026). Reduced-Resistances Model for Enhanced Drug Permeation via a Solubilizing Receiver Medium: A Mechanistic Study with Hollow Fiber Membranes. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01771

Vancouver

Murray JD, Patel RP, Bennett-Lenane H, O'Dwyer PJ, Griffin BT, Polli JE. Reduced-Resistances Model for Enhanced Drug Permeation via a Solubilizing Receiver Medium: A Mechanistic Study with Hollow Fiber Membranes. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01771

BibTeX
@article{Murray2026,
  author = {Murray, Jack D and Patel, Roshni P and Bennett-Lenane, Harriet and O'Dwyer, Patrick J and Griffin, Brendan T and Polli, James E},
  title = {Reduced-Resistances Model for Enhanced Drug Permeation via a Solubilizing Receiver Medium: A Mechanistic Study with Hollow Fiber Membranes},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01771}
}
Kostenlos starten →